DeepDyve
Login
Login failed. Please try again.
Forgot your password?
Login with Facebook
Close
Please enable Javascript on your browser for a better experience on DeepDyve.
Enter a sentence, or cut and paste a paragraph
Refine
Advanced Filters »
All Edit
Select All | Select None
Reset filters Search
Journals The FASEB Journal July 2009
To view this document, you will need to have Adobe Flash Player 10 or above installed.Please click here to install.
Post-myocardial infarction (MI) heart failure is a major public health problem in Western countries and results from ischemia/reperfusion (IR)-induced cell death, remodeling, and contractile dysfunction. Ex vivo studies have demonstrated the cardioprotective anti-inflammatory effect of the cannabinoid type 2 (CB2) receptor agonists within hours after IR. Herein, we evaluated the in vivo effect of CB2 receptors on IR-induced cell death, fibrosis, and cardiac dysfunction and investigated the target role of cardiac myocytes and fibroblasts. The infarct size was increased 24 h after IR in CB2 –/– vs. wild-type (WT) hearts and decreased when WT hearts were injected with the CB2 agonist JWH133 (3 mg/kg) at reperfusion. Compared with WT hearts, CB2 –/– hearts showed widespread injury 3 d after IR, with enhanced apoptosis and remodeling affecting the remote myocardium. Finally, CB2 –/– hearts exhibited exacerbated fibrosis, associated with left ventricular dysfunction 4 wk after IR, whereas their WT counterparts recovered normal function. Cardiac myocytes and fibroblasts isolated from CB2 –/– hearts displayed a higher H 2 O 2 -induced death than WT cells, whereas 1 µM JWH133 triggered survival effects. Furthermore, H 2 O 2 -induced myofibroblast activation was increased in CB2 –/– fibroblasts but decreased in 1 µM JWH133-treated WT fibroblasts, compared with that in WT cells. Therefore, CB2 receptor activation may protect against post-IR heart failure through direct inhibition of cardiac myocyte and fibroblast death and prevention of myofibroblast activation.—Defer, N., Wan, J., Souktani, R., Escoubet, B., Perier, M., Caramelle, P., Manin, S., Deveaux, V., Bourin, M.-C., Zimmer, A., Lotersztajn, S., Pecker, F., Pavoine, C. The cannabinoid receptor type 2 promotes cardiac myocyte and fibroblast survival and protects against ischemia/reperfusion-induced cardiomyopathy.
To view this document, you will need to have Adobe Flash Player 10 or above installed. Please click here to install.
This is a preview. The total pages displayed will be limited.
Rent for $0.99 FREE
It seems like you have an account, please login to rent this article
Don't have an account yet? Sign up now!
To view the full-text of this article, sign up for a free DeepDyve account below.
A free Basic account also comes with 3 free rentals to help get you started.
Just 30 seconds to go! Please check your inbox for a confirmation email to activate your account, then start using your 3 FREE rentals.
Sign up with your Facebook account
Learn more Existing user? Login here
Share this article: facebook twitter
Browse: Subject Areas | Journals | Publishers
© 2010 DeepDyve, Inc. All rights reserved. Terms of Service | Privacy Policy
To bookmark an article, please log in first, or sign up for a DeepDyve account if you don't already have one.
OK
To subscribe to email alerts, please log in first, or sign up for a DeepDyve account if you don't already have one.